Laura Sanders, MD

  • 836 W. Wellington Avenue, Advocate Illinois Masonic Medical Center, Chicago, Illinois,60657
    773-296-8000
  • 3982 N. Milwaukee Avenue, Chicago Eye Institute, Chicago, Illinois,60651
    773-282-2000
  • 1431 N. Western Avenue, St. Elizabeth\'s Hospital, Chicago, Illinois,60622
    773-342-8000
  • 2525 S Michigan Avenue, Chicago, Illinois,60616
    312-236-6575

Treatment with Restasis

 

 

What is RESTASIS®?

  • RESTASIS® is the only prescription eye drop that helps increase your eyes’ natural ability to produce tears, which could be reduced by inflammation due to Chronic Dry Eye. RESTASIS® Ophthalmic Emulsion did not increase tear production in patients using topical steroids or tear duct plugs.
  • Research has shown that Chronic Dry Eye (keratoconjunctivitis sicca, may also be called Dry Eye Syndrome) could be the result of a functional problem in the tear-producing glands of the eyes. This reduces tear production, resulting in an insufficient amount of tears to lubricate or nourish the eye

How does it work?

  • RESTASIS® Ophthalmic Emulsion is the initially prescription eye drop indicated to increase tear production which could be reduced by inflammation on the eye surface in patients with Chronic Dry Eye.
  • RESTASIS® did not increase tear production in patients using topical steroid drops or tear duct plugs.
  • The approved treatment is one drop in the morning and one drop at night in each eye, every day.
  • RESTASIS® Ophthalmic Emulsion helps increase your natural ability to produce tears, which could be reduced by inflammation due to Chronic Dry Eye.
  • RESTASIS® is believed to work on the inflammation to relieve it and enable greater tear production over time.

What are the side effects?

  • The most common side effect reported by 17% of patients was ocular burning. 
  • Other side effects reported by 1% to 5% of patients included conjunctival hyperemia, discharge, epiphora, eye pain, foreign-body sensation, pruritus, stinging, and visual disturbance (most often blurring). 
  • RESTASIS® is contraindicated in patients with active ocular infections and has not been studied in patients with a history of herpes keratitis.

 

Office Locations